Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.

Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market

The global Prostate Specific Antigen (PSA) Blood Based Biomarker market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Prostate Specific Antigen (PSA) Blood Based Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Prostate Specific Antigen (PSA) Blood Based Biomarker include ProteoMediX, Cleveland Diagnostics, Randox, Roche, GENFIT, Nutech Cancer Biomarkers, OGT (Sysmex Group), Minomic and Creative Diagnostics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Prostate Specific Antigen (PSA) Blood Based Biomarker is widely used in various fields, such as Diagnostics, Drug Discovery, Personalized Medicine and Others, etc. Diagnostics provides greatest supports to the Prostate Specific Antigen (PSA) Blood Based Biomarker industry development. In 2023, global % revenue of Prostate Specific Antigen (PSA) Blood Based Biomarker went into Diagnostics filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Prostate Specific Antigen (PSA) Blood Based Biomarker market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prostate Specific Antigen (PSA) Blood Based Biomarker, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Specific Antigen (PSA) Blood Based Biomarker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Specific Antigen (PSA) Blood Based Biomarker revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Specific Antigen (PSA) Blood Based Biomarker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Specific Antigen (PSA) Blood Based Biomarker revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Prostate Specific Antigen (PSA) Blood Based Biomarker Market Report

Report Metric	Details
Report Name	Prostate Specific Antigen (PSA) Blood Based Biomarker Market
Segment by Type	Screening Biomarker Diagnosis Biomarker
Segment by Application	Diagnostics Drug Discovery Personalized Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ProteoMediX, Cleveland Diagnostics, Randox, Roche, GENFIT, Nutech Cancer Biomarkers, OGT (Sysmex Group), Minomic, Creative Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Specific Antigen (PSA) Blood Based Biomarker in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Blood Based Biomarker companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Specific Antigen (PSA) Blood Based Biomarker revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market report?

Ans: The main players in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market are ProteoMediX, Cleveland Diagnostics, Randox, Roche, GENFIT, Nutech Cancer Biomarkers, OGT (Sysmex Group), Minomic, Creative Diagnostics

What are the Application segmentation covered in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market report?

Ans: The Applications covered in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market report are Diagnostics, Drug Discovery, Personalized Medicine, Others

What are the Type segmentation covered in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market report?

Ans: The Types covered in the Prostate Specific Antigen (PSA) Blood Based Biomarker Market report are Screening Biomarker, Diagnosis Biomarker

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Screening Biomarker

1.2.3 Diagnosis Biomarker

1.3 Market by Application

1.3.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Perspective (2019-2030)

2.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Trends by Region

2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Region (2019-2024)

2.2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Region (2025-2030)

2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Dynamics

2.3.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Trends

2.3.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers

2.3.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges

2.3.4 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Prostate Specific Antigen (PSA) Blood Based Biomarker by Players

3.1.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2019-2024)

3.1.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio

3.4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2023

3.5 Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker Head office and Area Served

3.6 Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Product and Application

3.7 Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Type

4.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Type (2019-2024)

4.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2025-2030)

5 Prostate Specific Antigen (PSA) Blood Based Biomarker Breakdown Data by Application

5.1 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Historic Market Size by Application (2019-2024)

5.2 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2019-2030)

6.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type

6.2.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024)

6.2.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030)

6.2.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

6.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

6.3.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024)

6.3.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030)

6.3.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

6.4 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

6.4.1 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024)

6.4.3 North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2019-2030)

7.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type

7.2.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024)

7.2.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030)

7.2.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

7.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

7.3.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024)

7.3.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030)

7.3.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

7.4 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

7.4.1 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024)

7.4.3 Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2019-2030)

8.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type

8.2.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024)

8.2.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030)

8.2.3 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

8.3 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

8.3.1 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024)

8.3.2 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030)

8.3.3 China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2019-2030)

9.2 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type

9.2.1 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024)

9.2.2 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030)

9.2.3 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

9.3 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

9.3.1 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024)

9.3.2 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030)

9.3.3 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

9.4 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region

9.4.1 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2019-2024)

9.4.3 Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type

10.2.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application

10.3.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country

10.4.1 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 ProteoMediX

11.1.1 ProteoMediX Company Details

11.1.2 ProteoMediX Business Overview

11.1.3 ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.1.4 ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.1.5 ProteoMediX Recent Developments

11.2 Cleveland Diagnostics

11.2.1 Cleveland Diagnostics Company Details

11.2.2 Cleveland Diagnostics Business Overview

11.2.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.2.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.2.5 Cleveland Diagnostics Recent Developments

11.3 Randox

11.3.1 Randox Company Details

11.3.2 Randox Business Overview

11.3.3 Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.3.4 Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.3.5 Randox Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.4.5 Roche Recent Developments

11.5 GENFIT

11.5.1 GENFIT Company Details

11.5.2 GENFIT Business Overview

11.5.3 GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.5.4 GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.5.5 GENFIT Recent Developments

11.6 Nutech Cancer Biomarkers

11.6.1 Nutech Cancer Biomarkers Company Details

11.6.2 Nutech Cancer Biomarkers Business Overview

11.6.3 Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.6.4 Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.6.5 Nutech Cancer Biomarkers Recent Developments

11.7 OGT (Sysmex Group)

11.7.1 OGT (Sysmex Group) Company Details

11.7.2 OGT (Sysmex Group) Business Overview

11.7.3 OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.7.4 OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.7.5 OGT (Sysmex Group) Recent Developments

11.8 Minomic

11.8.1 Minomic Company Details

11.8.2 Minomic Business Overview

11.8.3 Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.8.4 Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.8.5 Minomic Recent Developments

11.9 Creative Diagnostics

11.9.1 Creative Diagnostics Company Details

11.9.2 Creative Diagnostics Business Overview

11.9.3 Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Introduction

11.9.4 Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

11.9.5 Creative Diagnostics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ProteoMediX

Cleveland Diagnostics

Randox

Roche

GENFIT

Nutech Cancer Biomarkers

OGT (Sysmex Group)

Minomic

Creative Diagnostics

List of Tables

Table 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Screening Biomarker

Table 3. Key Players of Diagnosis Biomarker

Table 4. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region (2019-2024)

Table 8. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region (2025-2030)

Table 10. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends

Table 11. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Drivers

Table 12. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Challenges

Table 13. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Restraints

Table 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Players (2019-2024)

Table 16. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2023)

Table 17. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Headquarters and Area Served

Table 20. Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Product and Application

Table 21. Global Key Players of Prostate Specific Antigen (PSA) Blood Based Biomarker, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2019-2024)

Table 25. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Market Share by Type (2025-2030)

Table 27. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Application (2019-2024)

Table 29. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue Share by Application (2025-2030)

Table 31. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size by Country (2025-2030) & (US$ Million)

Table 63. ProteoMediX Company Details

Table 64. ProteoMediX Business Overview

Table 65. ProteoMediX Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 66. ProteoMediX Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 67. ProteoMediX Recent Developments

Table 68. Cleveland Diagnostics Company Details

Table 69. Cleveland Diagnostics Business Overview

Table 70. Cleveland Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 71. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 72. Cleveland Diagnostics Recent Developments

Table 73. Randox Company Details

Table 74. Randox Business Overview

Table 75. Randox Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 76. Randox Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 77. Randox Recent Developments

Table 78. Roche Company Details

Table 79. Roche Business Overview

Table 80. Roche Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 81. Roche Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 82. Roche Recent Developments

Table 83. GENFIT Company Details

Table 84. GENFIT Business Overview

Table 85. GENFIT Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 86. GENFIT Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 87. GENFIT Recent Developments

Table 88. Nutech Cancer Biomarkers Company Details

Table 89. Nutech Cancer Biomarkers Business Overview

Table 90. Nutech Cancer Biomarkers Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 91. Nutech Cancer Biomarkers Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 92. Nutech Cancer Biomarkers Recent Developments

Table 93. OGT (Sysmex Group) Company Details

Table 94. OGT (Sysmex Group) Business Overview

Table 95. OGT (Sysmex Group) Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 96. OGT (Sysmex Group) Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 97. OGT (Sysmex Group) Recent Developments

Table 98. Minomic Company Details

Table 99. Minomic Business Overview

Table 100. Minomic Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 101. Minomic Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 102. Minomic Recent Developments

Table 103. Creative Diagnostics Company Details

Table 104. Creative Diagnostics Business Overview

Table 105. Creative Diagnostics Prostate Specific Antigen (PSA) Blood Based Biomarker Product

Table 106. Creative Diagnostics Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024) & (US$ Million)

Table 107. Creative Diagnostics Recent Developments

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type: 2023 VS 2030

Figure 3. Screening Biomarker Features

Figure 4. Diagnosis Biomarker Features

Figure 5. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application: 2023 VS 2030

Figure 7. Diagnostics Case Studies

Figure 8. Drug Discovery Case Studies

Figure 9. Personalized Medicine Case Studies

Figure 10. Others Case Studies

Figure 11. Prostate Specific Antigen (PSA) Blood Based Biomarker Report Years Considered

Figure 12. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region: 2023 VS 2030

Figure 15. Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Players in 2023

Figure 16. Global Top Prostate Specific Antigen (PSA) Blood Based Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Blood Based Biomarker as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Blood Based Biomarker Revenue in 2023

Figure 18. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

Figure 20. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

Figure 21. North America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2019-2030)

Figure 22. United States Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

Figure 26. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

Figure 27. Europe Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2019-2030)

Figure 28. Germany Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

Figure 36. China Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

Figure 37. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

Figure 39. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

Figure 40. Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Region (2019-2030)

Figure 41. Japan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Prostate Specific Antigen (PSA) Blood Based Biomarker Market Share by Country (2019-2030)

Figure 51. Brazil Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. ProteoMediX Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 58. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 59. Randox Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 61. GENFIT Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 62. Nutech Cancer Biomarkers Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 63. OGT (Sysmex Group) Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 64. Minomic Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 65. Creative Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Blood Based Biomarker Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions